SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $23,000 | +15.0% | 29,524 | +89.3% | 0.00% | – |
| Q4 2021 | $20,000 | -85.7% | 15,597 | -54.5% | 0.00% | -100.0% |
| Q3 2020 | $140,000 | -84.6% | 34,252 | -67.6% | 0.00% | -83.3% |
| Q2 2019 | $909,000 | +64.4% | 105,556 | +104.1% | 0.01% | +50.0% |
| Q1 2019 | $553,000 | -79.6% | 51,714 | -83.3% | 0.00% | -80.0% |
| Q4 2018 | $2,708,000 | +162.1% | 309,497 | +519.0% | 0.02% | +300.0% |
| Q3 2018 | $1,033,000 | -85.3% | 50,000 | -85.1% | 0.01% | -84.4% |
| Q2 2018 | $7,022,000 | +13.8% | 335,028 | -12.6% | 0.03% | +23.1% |
| Q1 2018 | $6,169,000 | -42.0% | 383,423 | -31.6% | 0.03% | -21.2% |
| Q4 2017 | $10,629,000 | +13885.5% | 560,918 | +4348.9% | 0.03% | +3200.0% |
| Q4 2015 | $76,000 | -97.6% | 12,608 | -96.6% | 0.00% | -97.6% |
| Q3 2013 | $3,129,000 | +179.6% | 373,336 | +148.9% | 0.04% | +121.1% |
| Q2 2013 | $1,119,000 | – | 150,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |